1 false false false false false false false false false false true false false false false false false No description of principal activity 2024-05-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 14821500 2024-05-01 2025-01-31 14821500 2025-01-31 14821500 2024-04-30 14821500 2023-04-24 2024-04-30 14821500 2024-04-30 14821500 2023-04-23 14821500 bus:Director1 2024-05-01 2025-01-31 14821500 core:WithinOneYear 2025-01-31 14821500 core:WithinOneYear 2024-04-30 14821500 core:ShareCapital 2025-01-31 14821500 core:ShareCapital 2024-04-30 14821500 core:RetainedEarningsAccumulatedLosses 2025-01-31 14821500 core:RetainedEarningsAccumulatedLosses 2024-04-30 14821500 bus:SmallEntities 2024-05-01 2025-01-31 14821500 bus:AuditExemptWithAccountantsReport 2024-05-01 2025-01-31 14821500 bus:SmallCompaniesRegimeForAccounts 2024-05-01 2025-01-31 14821500 bus:PrivateLimitedCompanyLtd 2024-05-01 2025-01-31 14821500 bus:AbridgedAccounts 2024-05-01 2025-01-31
COMPANY REGISTRATION NUMBER: 14821500

Project Genetics Ltd

Filleted Unaudited Abridged Financial Statements

31 January 2025

Project Genetics Ltd

Abridged Statement of Financial Position

31 January 2025

| 31 Jan 25 | 30 Apr 24
Note | £ | £

Current assets

Debtors | 16,284 | 19,669
Cash at bank and in hand | 6,500 | 8,187
| -------- | --------
| 22,784 | 27,856

Creditors: amounts falling due within one year | 133,294 | 93,780
| --------- | --------
Net current liabilities | 110,510 | 65,924
| --------- | --------
Total assets less current liabilities | ( 110,510) | ( 65,924)
| --------- | --------

Capital and reserves

Called up share capital | 1 | 1
Profit and loss account | ( 110,511) | ( 65,925)
| --------- | --------
Shareholders deficit | ( 110,510) | ( 65,924)
| --------- | --------

These abridged financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the abridged statement of comprehensive income has not been delivered.
For the period ending 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its abridged financial statements for the period in question in accordance with section 476 ;
- The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of abridged financial statements .
All of the members have consented to the preparation of the abridged statement of comprehensive income and the abridged statement of financial position for the period ending 31 January 2025 in accordance with Section 444(2A) of the Companies Act 2006.

Project Genetics Ltd

Abridged Statement of Financial Position (continued)

31 January 2025
These abridged financial statements were approved by the board of directors and authorised for issue on 21 May 2025 , and are signed on behalf of the board by:

Ms J Axline |
Director |

Company registration number: 14821500

Project Genetics Ltd

Notes to the Abridged Financial Statements

Period from 1 May 2024 to 31 January 2025
1. General information
The company is a private company limited by shares, registered in England. The address of the registered office is 5th Floor, 18 St. Swithin's lane, London, EC4N 8AD, England.
2. Statement of compliance
These abridged financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The abridged financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The abridged financial statements are prepared in sterling, which is the functional currency of the entity.
Cessation
The financial statements have been prepared for a 9 month period with comparatives for a 12 month period which will not be entirely comparable. The directors decided to cease the business activities on 31 January 2025. Due to the proposed winding-up of the company, the directors have determined that the going concern basis (as applied in previous years) is no longer appropriate and these accounts have been prepared on a liquidation basis. Under the liquidation basis of preparation, assets and liabilities are measured at the liquidation value. The liquidation value of assets is their net realisable value. Net realisable value is based on the proceeds receivable on disposal less restructure and liquidation cost. The liquidation value of liabilities is their expected settlement amount. Under the liquidation basis of account, all assets and liabilities are classified as current. Comparative information has not been restated, and is measured and presented on a going concern basis
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Foreign currencies
Foreign currency transactions are initially recorded in the functional currency, by applying the spot exchange rate as at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated at the exchange rate ruling at the reporting date, with any gains or losses being taken to the profit and loss account.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
Defined contribution plans
Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.
4. Employee numbers
The average number of persons employed by the company during the period amounted to 1 (2024: 1 ).